CEO and Chairman of NuVasive Inc. (NUVA, Financial) Alexis V Lukianov sells 20,000 shares of NUVA on 08/07/2009 at an average price of $42.43 a share.
NUVASIVE is a medical device company focused on the design development and marketing of products for the surgical treatment of spine disorders. The Company\'s product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company\'s current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery or MAS as well as a growing offering of cervical and motion preservation products. NuVasive Inc. has a market cap of $1.5 billion; its shares were traded at around $41.27 with a P/E ratio of 165.1 and P/S ratio of 6.
Recent Trades of NuVasive Inc. by CEO:
Recent Trades of NuVasive Inc. by CFO:
Recent Trades of NuVasive Inc. by Directors and Officers:
NUVASIVE is a medical device company focused on the design development and marketing of products for the surgical treatment of spine disorders. The Company\'s product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company\'s current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery or MAS as well as a growing offering of cervical and motion preservation products. NuVasive Inc. has a market cap of $1.5 billion; its shares were traded at around $41.27 with a P/E ratio of 165.1 and P/S ratio of 6.
Recent Trades of NuVasive Inc. by CEO:
- Sell: CEO and Chairman Alexis V Lukianov sold 20,000 shares of NUVA stock on 07/08/2009 at the average price of $39.88; the price of the stock has increased by 3.49% since.
- Sell: CEO and Chairman Alexis V Lukianov sold 20,000 more shares of NUVA stock on 07/08/2009 at the average price of $39.88; the price of the stock has increased by 3.49% since.
- Sell: CEO and Chairman Alexis V Lukianov sold 20,000 more shares of NUVA stock on 06/05/2009 at the average price of $41.14; the price of the stock has increased by 0.32% since.
- Sell: CEO and Chairman Alexis V Lukianov sold 15,000 more shares of NUVA stock on 05/07/2009 at the average price of $37.7; the price of the stock has increased by 9.47% since.
- Sell: CEO and Chairman Alexis V Lukianov sold 10,000 more shares of NUVA stock on 04/08/2009 at the average price of $30; the price of the stock has increased by 37.57% since.
Recent Trades of NuVasive Inc. by CFO:
- Sell: CFO and Executive VP Kevin C Oboyle sold 6,000 shares of NUVA stock on 07/15/2009 at the average price of $40.26; the price of the stock has increased by 2.51% since.
- Sell: CFO and Executive VP Kevin C Oboyle sold 6,000 more shares of NUVA stock on 06/12/2009 at the average price of $42.67; the price of the stock has decreased by 3.28% since.
- Sell: CFO and Executive VP Kevin C Oboyle sold 6,000 more shares of NUVA stock on 05/14/2009 at the average price of $36; the price of the stock has increased by 14.64% since.
- Sell: CFO and Executive VP Kevin C Oboyle sold 6,000 more shares of NUVA stock on 02/13/2009 at the average price of $39.03; the price of the stock has increased by 5.74% since.
Recent Trades of NuVasive Inc. by Directors and Officers:
- Sell: Senior V.P., U.S. Sales Jeffrey P Rydin sold 19,000 shares of NUVA stock on 07/27/2009 at the average price of $41.09; the price of the stock has increased by 0.44% since.
- Sell: EVP, Marketing and Development Patrick Miles sold 5,000 shares of NUVA stock on 07/23/2009 at the average price of $42.73; the price of the stock has decreased by 3.42% since.
- Sell: EVP, Marketing and Development Patrick Miles sold 5,000 more shares of NUVA stock on 07/23/2009 at the average price of $42.73; the price of the stock has decreased by 3.42% since.
- Sell: EVP, Marketing and Development Patrick Miles sold 5,000 more shares of NUVA stock on 07/23/2009 at the average price of $42.73; the price of the stock has decreased by 3.42% since.
- Sell: President and COO Keith Valentine sold 8,000 shares of NUVA stock on 07/21/2009 at the average price of $40.71; the price of the stock has increased by 1.38% since.
